Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Sanofi (SNY) Income from Non-Controlling Interests (2016 - 2026)

Sanofi's Income from Non-Controlling Interests history spans 16 years, with the latest figure at $7.0 million for Q1 2026.

  • On a quarterly basis, Income from Non-Controlling Interests fell 68.2% to $7.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $28.5 million, a 10.33% increase, with the full-year FY2025 number at $44.2 million, down 28.63% from a year prior.
  • Income from Non-Controlling Interests hit $7.0 million in Q1 2026 for Sanofi, down from $39.6 million in the prior quarter.
  • Over the last five years, Income from Non-Controlling Interests for SNY hit a ceiling of $58.2 million in Q4 2022 and a floor of -$54.3 million in Q2 2025.
  • Historically, Income from Non-Controlling Interests has averaged $13.3 million across 5 years, with a median of $14.1 million in 2024.
  • The widest YoY moves for Income from Non-Controlling Interests: up 497.27% in 2024, down 413.17% in 2024.
  • Tracing SNY's Income from Non-Controlling Interests over 5 years: stood at $58.2 million in 2022, then plummeted by 105.55% to -$3.2 million in 2023, then surged by 497.27% to $12.8 million in 2024, then soared by 208.64% to $39.6 million in 2025, then plummeted by 82.25% to $7.0 million in 2026.
  • Business Quant data shows Income from Non-Controlling Interests for SNY at $7.0 million in Q1 2026, $39.6 million in Q4 2025, and $36.2 million in Q3 2025.